Business
ResMed eyes ‘U-shaped’ recovery after ventilator boom – Sydney Morning Herald
The ventilator maker posted a 24 per cent jump in operating profit but acknowledges demand won’t last.
The $40 billion respiratory treatments provider has excited the market with strong quarterly earnings throughout the pandemic as the company fast-tracked production of 150,000 ventilators to meet global demand as COVID-19 took hold.
The business, which has shares listed on the New York and Australian exchanges, revealed on Thursday it had achieved 15 per cent revenue growth for 2020 on a constant currency basis, hitting $US3 billion.
Operating profit was $US243 million for the year, up 24 per …
-
Noosa News23 hours agoTop chefs rally for Noosa Reds farmers Pete and Dory
-
Noosa News14 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Business21 hours agoThis ASX healthcare stock could be a buy low bargain
-
Business19 hours agoprofit up 24%, outlook strong